236 related articles for article (PubMed ID: 22236408)
41. Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.
Bandara G; Muñoz-Cano R; Tobío A; Yin Y; Komarow HD; Desai A; Metcalfe DD; Olivera A
Front Immunol; 2018; 9():631. PubMed ID: 29643855
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of sphingosine kinase inhibitors.
French KJ; Upson JJ; Keller SN; Zhuang Y; Yun JK; Smith CD
J Pharmacol Exp Ther; 2006 Aug; 318(2):596-603. PubMed ID: 16632640
[TBL] [Abstract][Full Text] [Related]
43. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.
Kapitonov D; Allegood JC; Mitchell C; Hait NC; Almenara JA; Adams JK; Zipkin RE; Dent P; Kordula T; Milstien S; Spiegel S
Cancer Res; 2009 Sep; 69(17):6915-23. PubMed ID: 19723667
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal.
Gude DR; Alvarez SE; Paugh SW; Mitra P; Yu J; Griffiths R; Barbour SE; Milstien S; Spiegel S
FASEB J; 2008 Aug; 22(8):2629-38. PubMed ID: 18362204
[TBL] [Abstract][Full Text] [Related]
45. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
[TBL] [Abstract][Full Text] [Related]
46. Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells.
Yang YL; Ji C; Cheng L; He L; Lu CC; Wang R; Bi ZG
Cancer Sci; 2012 Aug; 103(8):1538-45. PubMed ID: 22594559
[TBL] [Abstract][Full Text] [Related]
47. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
48. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
[TBL] [Abstract][Full Text] [Related]
49. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
50. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.
Paugh SW; Paugh BS; Rahmani M; Kapitonov D; Almenara JA; Kordula T; Milstien S; Adams JK; Zipkin RE; Grant S; Spiegel S
Blood; 2008 Aug; 112(4):1382-91. PubMed ID: 18511810
[TBL] [Abstract][Full Text] [Related]
51. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
Wu X; Zhu M; Fletcher JA; Giobbie-Hurder A; Hodi FS
PLoS One; 2012; 7(1):e29622. PubMed ID: 22253748
[TBL] [Abstract][Full Text] [Related]
52. Progesterone-induced sphingosine kinase-1 expression in the rat uterus during pregnancy and signaling consequences.
Jeng YJ; Suarez VR; Izban MG; Wang HQ; Soloff MS
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1110-21. PubMed ID: 17164439
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.
Zhang H; Li W; Sun S; Yu S; Zhang M; Zou F
Cell Prolif; 2012 Apr; 45(2):167-75. PubMed ID: 22288844
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma.
Gowda R; Madhunapantula SV; Desai D; Amin S; Robertson GP
Mol Cancer Ther; 2013 Jan; 12(1):3-15. PubMed ID: 23112250
[TBL] [Abstract][Full Text] [Related]
55. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
56. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
Bhatt KV; Spofford LS; Aram G; McMullen M; Pumiglia K; Aplin AE
Oncogene; 2005 May; 24(21):3459-71. PubMed ID: 15735667
[TBL] [Abstract][Full Text] [Related]
57. TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition.
Lima S; Takabe K; Newton J; Saurabh K; Young MM; Leopoldino AM; Hait NC; Roberts JL; Wang HG; Dent P; Milstien S; Booth L; Spiegel S
Autophagy; 2018; 14(6):942-957. PubMed ID: 29368980
[TBL] [Abstract][Full Text] [Related]
58. Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance.
Antoon JW; White MD; Burow ME; Beckman BS
Oncol Rep; 2012 Jun; 27(6):1779-86. PubMed ID: 22469881
[TBL] [Abstract][Full Text] [Related]
59. Sphk1 promotes breast epithelial cell proliferation via NF-κB-p65-mediated cyclin D1 expression.
Li S; Zhou Y; Zheng X; Wu X; Liang Y; Wang S; Zhang Y
Oncotarget; 2016 Dec; 7(49):80579-80585. PubMed ID: 27811358
[TBL] [Abstract][Full Text] [Related]
60. SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice.
Chiba Y; Takeuchi H; Sakai H; Misawa M
J Pharmacol Sci; 2010; 114(3):304-10. PubMed ID: 20948165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
